Life Sciences Executive and Legal Expert Joins Board of the Cancer Prevention Institute of California

Industry Strategist Elona Baum lends expertise to advance cancer prevention

Elona Baum
FREMONT, CA (April 11, 2014) — Elona Baum, a seasoned executive and legal expert in the life sciences field, has joined the board of trustees of the Cancer Prevention Institute of California (CPIC).  Baum, who is general counsel and vice president of business development for the California Institute for Regenerative Medicine (CIRM), brings to CPIC more than 20 years of legal and business expertise in the biotechnology and regenerative medicine areas.

“Cancer is a devastating disease and there is so much opportunity to lessen its impact and improve care,” Baum said. “CPIC’s innovative research has already made a difference and, as a board member, I look forward to ensuring CPIC continues its long history of scientific excellence and public education.”

Baum has served on the executive team of CIRM since 2009, and is responsible for the strategic initiatives of the agency and oversight of its legal functions.  She engages in outreach to industry and develops innovative funding programs to advance regenerative medicine research and development.

Prior to joining CIRM, Baum held various positions over her 12-year tenure at Genentech Inc., including associate general counsel, director of regulatory policy and strategy, and secretary of the board of directors for Genentech’s Spanish subsidiary, Genentech Espana.

“We are thrilled to have Elona’s expertise in research funding, strategic planning, legal policy, and regulatory matters as an addition to our board skill set,” said Samuel Bronfman II, CPIC’s board chairman. “Her familiarity with industry outreach and partnering, venture capital, business development, and her broad experience in the biotechnology industry will be of great value to CPIC as we plan our future.”

Baum joins 12 other trustees whose leadership supports CPIC’s population-based cancer prevention research and community education programs. She will have an opportunity to share her skills and expertise by choosing to serve on various board committees for the organization.

A frequent speaker at industry conferences, Baum is a member of the Rick Hansen Institute’s Commercialization Advisory Committee.  In 2013 she served as a delegate to the G8 Summit on Dementia and was a member of the expert focus group that considered global funding models and the appointment of a dementia innovation envoy.

Baum began her legal career at private law firms in the San Francisco Bay Area.  She holds a bachelor’s degree in economics from the University of California, Los Angeles, and a juris doctorate from the University of San Francisco School of Law.

About the Cancer Prevention Institute of California
The Cancer Prevention Institute of California (CPIC) is the nation’s premier organization dedicated to preventing cancer and to reducing its burden where it cannot yet be prevented. CPIC tracks patterns of cancer throughout the entire population and identifies those at risk for developing cancer. Its research scientists are leaders in investigating the causes of cancer in large populations to advance the development of prevention-focused interventions. CPIC’s innovative cancer prevention research and education programs, together with the work of the Stanford Cancer Institute, deliver a comprehensive arsenal for defeating cancer. For more information, visit CPIC’s official website at


Media Contact: Jana Cuiper, 510-608-5160 |

© Cancer Prevention Institute of California